Get Assistance With the New Omnitrope Co-Pay Savings Program

Savings support can help make growth hormone therapy more affordable

The new Omnitrope Co-Pay Savings Program may provide an upfront benefit of up to $5,000 each year. That means this benefit can be applied at any time once your eligibility is confirmed.

Maximum benefit of up to $5,000 to be used at any time, annually for eligible* patient

$0 co-pay for eligible* patient

Upfront benefit provides immediate support for patients starting Omnitrope

Eligible patients may include*:

Patients with high deductibles

Co-insured patients

Cash-paying patients

Call 877.456.6794 (Mon – Fri, 8AM – 8PM ET) to get started

*Omnitrope Co-Pay Savings Program Eligibility

The Omnitrope Co-Pay Savings Program provides up to $5,000 in annual co-pay support for Omnitrope prescriptions. With the Omnitrope Co-Pay Savings Program, eligible patients may pay $0 for their co-pay. Eligible patients who are commercially insured may receive co-pay support in the amount of up to $5,000 annually, and patients who are uninsured may receive co-pay support in the amount of up to $417 monthly, with an annual cap of $5,000. Prescription must be for an approved indication. This program is not health insurance. Patients are not eligible if prescriptions are paid, in whole or in part, by any state or federally funded programs, including but not limited to Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, or TriCare, or private indemnity, or HMO insurance plans that reimburse you for the entire cost of your prescription drugs, or where prohibited by law. Patients can participate for a maximum of 12 months. Eligible patients must have a first use of the program by December 31 of the current year. Omnitrope Co-Pay Savings Program may not be combined with any other rebate, coupon, or offer. Omnitrope Co-Pay Savings Program has no cash value. Sandoz reserves the right to rescind, revoke, or amend this offer without further notice. 

INDICATIONS

Omnitrope is a recombinant human growth hormone indicated for :

  • Pediatric: Treatment of children with growth failure due to growth hormone deficiency (GHD), Prader-Willi Syndrome, Small for Gestational Age, Turner Syndrome, and Idiopathic Short Stature
  • Adult: Treatment of adults with either adult onset or childhood onset GHD

IMPORTANT SAFETY INFORMATION

Who should not take Omnitrope®?

Omnitrope should not be used in children and adults with any of the following medical conditions because serious side effects, including death, can occur:

  • a critical illness caused by certain types of heart or stomach surgery, serious injury or a sudden and severe breathing problem (respiratory failure)
  • Prader-Willi syndrome who are severely overweight or have a history of breathing problems including sleep apnea
  • cancer or other tumors
  • allergies to growth hormone or any of the ingredients in the medicine
  • certain types of eye problems caused by diabetes

Omnitrope should also not be used in children who have completed growth

What should patients tell their doctor before taking Omnitrope?

Patients should tell their doctor about their medical and family history, treatment use and past and existing medical conditions, such as but not limited to the following:

  • cancer or any tumor
  • diabetes
  • use of prescription and non-prescription medicines, steroids, vitamins, and herbal supplements
  • pregnancy
  • nursing

What are the most common side effects of Omnitrope?

  • local reactions at the injection site (such as pain, numbness, redness and swelling)
  • headaches
  • swelling associated with fluid retention
  • pain in joints and muscle pain
  • carpal tunnel syndrome
  • tingling and numbness
  • high blood sugar (hyperglycemia/diabetes) and sugar in your urine (glucosuria)
  • unusual skin sensations
  • low levels of thyroid hormone (hypothyroidism)

Show more....